Joan Merrill to Transmembrane Activator and CAML Interactor Protein
This is a "connection" page, showing publications Joan Merrill has written about Transmembrane Activator and CAML Interactor Protein.
Connection Strength
0.740
-
Commentary: Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders. Front Immunol. 2020; 11:592639.
Score: 0.740
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.